Trial Profile
Atomoxetine's Effects On Nicotine Response And Stress Response In Smokers
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I/II
Latest Information Update: 25 May 2017
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary)
- Indications Smoking withdrawal
- Focus Therapeutic Use
- 19 May 2017 Status changed from suspended to withdrawn prior to enrolment.
- 17 Feb 2015 Status changed from recruiting to suspended due to funding as reported by ClinicalTrials.gov record.
- 03 May 2014 Status changed from not yet recruiting to recruiting, as per ClinicalTrials.gov record.